Login
$IMRX
$3.52 -$0.19 (5.12%) Live

Company Executives

Officer Age In this role 2025 pay Source
Benjamin J. Zeskind Also a director
Co-Founder, President, Chief Executive Officer, Director
44 Since 2008
18 years
$1,660,612
Andrew Gengos
Chief Financial Officer
Title from the Form 4 dated Jul 16, 2026
Not stated Not stated Not reported
Harold E. Brakewood
Chief Business Officer
61 Since 2023
3 years
Not reported
Brett Hall
Chief Scientific Officer
57 Since 2019
7 years
$1,289,504
Michael D. Bookman
Chief Legal Officer, Secretary
39 Since 2023
3 years
$890,362
Igor Matushansky
Chief Medical Officer
53 Since 2025
1 year
Not reported
Mallory Morales
Senior Vice President Finance, Chief Accounting Officer
42 Since 2026
this year
Not reported
Leah R. Neufeld
Chief People Officer
53 Since 2022
4 years
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 20, 2026 · updated by the 8-K of Nov 9, 2026

Directors
7
serving now
Independent
5 of 5
stated in the proxy; 2 not stated
Average tenure
8.5 years
from year joined
CEO also chairs the board
No
Thomas J. Schall, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Thomas J. Schall, Ph.D.
66 2024
2 years
Independent
Audit Committee
None stated $104,893
Benjamin J. Zeskind, Ph.D.
44 2008
18 years
Not stated None stated None stated Paid as CEO
Peter Feinberg
65 2021
5 years
Independent
Audit Committee Nominating and Corporate Governance Committee
None stated $103,379
Laurie B. Keating
72 2021
5 years
Independent None stated PepGen Inc. $106,811
Robert J. Carpenter
81 2009
17 years
Independent
Compensation Committee
None stated $93,521
Diana F. Hausman, M.D.
63 2022
4 years
Independent None stated None stated $101,521
Grant C. Bogle Joined Nov 9, 2026
- - - - - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

7 disclosed in the proxy filed Apr 20, 2026
Entities affiliated with Empery Asset Management, LP
Former holders of more than 5% of our Class A common stock
Amount not stated

Purchased 4,015,452 Class A shares and 1,077,764 pre-funded warrants in the August 2025 Private Placement

With us Open in proxy
Merrin Investors LLC
Former holder of more than 5% of our Class A common stock
Amount not stated

Purchased 539,696 Class A shares in the August 2025 Private Placement

With us Open in proxy
Entities affiliated with FMR LLC
Holder of more than 5% of our Class A common stock
Amount not stated

Purchased 7,679,476 Class A shares in the September 2025 Offering

With us Open in proxy
Entities affiliated with HBM Healthcare Investments (Cayman) Ltd.
Holder of more than 5% of our Class A common stock
Amount not stated

Purchased 2,708,559 Class A shares in the September 2025 Offering

With us Open in proxy
Entities affiliated with Empery Asset Management, LP
Former holder of more than 5% of our Class A common stock
Amount not stated

Purchased 541,711 Class A shares in the September 2025 Offering

With us Open in proxy
Ryan (Alex) Peterson
son-in-law of Brett Hall, Ph.D., our Chief Scientific Officer
$129,714
fiscal year 2025

Employed by the Company as Senior Manager, Logistics; received total compensation for fiscal year 2025

Each of our directors and executive officers
Directors and executive officers of the Company
Amount not stated

Indemnification agreements requiring the Company to indemnify directors and executive officers to the fullest extent permitted by Delaware law

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support